key: cord-0899207-i07svpo6 authors: Brandt, Justin S.; Fell, Deshayne B. title: SARS‐CoV‐2 infection in pregnancy: Lessons learned from the first pandemic wave date: 2021-01-26 journal: Paediatr Perinat Epidemiol DOI: 10.1111/ppe.12745 sha: 424dcb995618c0cf4419f53b36703a4b8b4c26a9 doc_id: 899207 cord_uid: i07svpo6 nan Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 55 million people worldwide and killed more than 1. . Early in the pandemic, pregnant women were considered at increased risk due to physiologic adaptations of pregnancy that make them vulnerable to complications from upper respiratory infections. While early reports of COVID-19 suggested pregnant women had similar outcomes compared with non-pregnant women, 1 recent surveillance data from the US Centers for Disease Control found that infected pregnant women were more likely to be admitted to the intensive care unit, receive mechanical ventilation, and die, compared with similarly aged, non-pregnant women. 2 Evidence on the epidemiology of COVID-19 in pregnancy, including risk factors for severe disease, has been elucidated, 3 but risk factors for SARS-CoV-2 infection remain less clear. As a result of hard earned experience during the initial wave of COVID-19, several interventions emerged that reduce the mortality risk, such as dexamethasone and other glucocorticoids, 4 and promising vaccines loom on the horizon. 5 The global community is now engaged in a second wave and is better prepared, but we continue to learn from our initial experiences with COVID-19. In this The study provides insight into risk factors for SARS-CoV-2 infection in pregnancy, but also illustrates several salient points about universal testing for SARS-CoV-2 in labour and delivery (L&D) settings, presence of identifiable risk factors, and vulnerability of pregnant non-health care essential workers and racial/ethnic minorities. What follows in this commentary is a discussion of these issues. The study hospitals adopted their strategy of universal testing on 19 April 2020, just one month after the WHO pandemic declaration. The rationale for routine testing in L&D in some US hospitals is largely based on the high proportion of asymptomatic infection. 7 Interaction of asymptomatic pregnant women with undetected SARS-CoV-2 infection with the health care system for obstetrical management, rather than for COVID-19-related medical compli- Most testing in the United States is allocated to symptomatic patients and those who are sick enough to require hospitalisation. Universal testing in L&D of mostly asymptomatic women therefore can also serve another purpose. Like the canary in the coal mine, universal testing of women presenting to L&D can alert public health officials about evolving epidemiology of local and regional infections. percentile or ≥ 95th percentile had threefold higher and 12-fold higher odds, respectively, of SARS-CoV-2 infection themselves. We do not know whether these are local "hot spots" or larger areas because the geographic configuration of at-risk areas is not shown in the study, but further research is needed to understand why some areas have more prevalent infections. There are likely local practices that drive high rates of viral transmission, such as attitudes about mask wearing or perceptions about social interaction and risks. Local initiatives to address these perceptions may have substantial benefits to reduce infection rates. 6.2, 95% CI 3.3, 11.2), whereas health care essential workers were at slightly reduced odds of infection (OR 0.8, 95% CI 0.3, 1.7) . While both groups of essential workers were likely exposed to SARS-CoV-2-infected individuals, health care workers were more likely to be exposed to infected and sicker individuals with overt manifestations of disease, yet, even in this context, they had lower rates of infection than non-health care essential workers. Reasons for disparate rates of infection among essential workers remain uncertain. Health care workers, by virtue of their professions, will undoubtedly have greater (and freer) access to PPE or a stronger commitment to use PPE, both shown to reduce transmission in health care settings. 9 Another potential explanation is driven by changes to social or occupational interactions with people known to have SARS-CoV-2 infection, which is much more likely to be known in health care settings. SARS-CoV-2 testing has limitations, but it is likely that knowledge of an individual's SARS-CoV-2 status results in behaviours that reduce the risk of transmission. Greater access to testing and ensuring access to PPE may minimise the occupational risk for pregnant, non-health care essential workers. The results of this study add to a growing body of literature about disproportionate outcomes for individuals from racial/ethnic minority groups during the COVID-19 pandemic. Compared with White women, Reale and colleagues found that Black women had a sixfold (95% CI 3.0, 11.9) higher odds of infection and Hispanic women had an 11-fold (95% CI 6.7, 18.7) higher odds. The observation of disproportionate rates of infection among Black and Hispanic women in this study likely translates to the greater morbidity and mortality associated with COVID-19 seen in other studies. This was demonstrated in the CDC surveillance report, which found that Black and Hispanic pregnant women had significantly higher rates of COVID-19-related deaths compared with White women. 2 The social and economic determinants of health that contribute to these disparities are unlikely to be solved soon, and certainly not before widespread availability of a vaccine. As there is evidence that Black people may have higher reluctance to vaccinate, 10 there is potential that this gap may widen before the end of this crisis. This will be a challenge for vaccine campaigns, which need to gain the trust of these communities or risk aggravating existing disparities. In summary, Reale and colleagues' prospective cohort study provides important insights on risk factors for SARS-CoV-2 infection in the obstetric population. The results illustrate the potential importance of universal testing in L&D, especially in communities with high transmission, given the high proportion of asymptomatic infection and implications for prevention in health care settings. Of particular concern are findings of increased risk for non-health care essential workers and those from racial/ethnic minority groups. We do not know whether the demographic characteristics reflect the fact that Black and Hispanic people are more at-risk because they live in communities with more risk or because they are more likely to be in essential jobs, and it would have been useful had the authors stratified by infection rates or use other techniques to tease out this question, but clearly strategies to reduce transmission rates among these populations require further study. As we respond to the challenges of the second wave of COVID-19, we still have much to learn, but we are better prepared too. The authors have no conflict of interests to declare. https://orcid.org/0000-0002-3194-1087 COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status -United States Epidemiology of coronavirus disease 2019 in pregnancy: risk factors and associations with adverse maternal and neonatal outcomes Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis Pfizer applies for emergency F.D.A. approval for Covid-19 vaccine Patient characteristics associated with SARS-CoV-2 infection in parturients admitted for labor and delivery in massachusetts during the spring 2020 surge: A prospective cohort study Universal Screening for SARS-CoV-2 in Women Admitted for Delivery Biden calls for sevenfold increase in testing as he details COVID-19 plan Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic -a narrative review Black Americans face higher COVID-19 risks, are more hesitant to trust medical scientists